A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination

OBJECTIVES: Antibody testing against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been instrumental in detecting previous exposures and analyzing vaccine‐elicited immune responses. Here, we describe a scalable solution to detect and quantify SARS‐CoV‐2 antibodies, discriminate be...

Descripción completa

Detalles Bibliográficos
Autores principales: Colwill, Karen, Galipeau, Yannick, Stuible, Matthew, Gervais, Christian, Arnold, Corey, Rathod, Bhavisha, Abe, Kento T, Wang, Jenny H, Pasculescu, Adrian, Maltseva, Mariam, Rocheleau, Lynda, Pelchat, Martin, Fazel‐Zarandi, Mahya, Iskilova, Mariam, Barrios‐Rodiles, Miriam, Bennett, Linda, Yau, Kevin, Cholette, François, Mesa, Christine, Li, Angel X, Paterson, Aimee, Hladunewich, Michelle A, Goodwin, Pamela J, Wrana, Jeffrey L, Drews, Steven J, Mubareka, Samira, McGeer, Allison J, Kim, John, Langlois, Marc‐André, Gingras, Anne‐Claude, Durocher, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942165/
https://www.ncbi.nlm.nih.gov/pubmed/35356067
http://dx.doi.org/10.1002/cti2.1380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942165/
https://www.ncbi.nlm.nih.gov/pubmed/35356067
http://dx.doi.org/10.1002/cti2.1380

Ejemplares similares